Mar 09, 2018 04:22 PM IST
Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 837 in its research report dated March 09, 2018.
- Mar 08, 2018 09:41 AM IST
In the current week, selling pressure was intensified on the breach of lower band of the broader consolidation range of 10300.
- Mar 08, 2018 08:36 AM IST
The Nifty50 is likely to open higher on Thursday tracking positive trend seen in other Asian markets. The index closed 95 points lower at 10,154.
- Feb 09, 2018 12:07 PM IST
ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 715 in its research report dated February 09, 2018.
- Jan 17, 2018 10:53 AM IST
In a BSE filing Ipca Laboratories announced "acquisition of 100 per cent share capital of Pisgah Labs Inc, a North Carolina Corporation" by Ipca Pharmaceutical Inc, USA and Onyx Scientific Ltd., U.K (Onyx) (company's wholly owned step down subsidiary) for USD 9.65 million free of debt".
- Nov 14, 2017 03:25 PM IST
The company had posted a net profit at Rs 54.95 crore during the same period of previous fiscal, Ipca Laboratories said in a regulatory filing.
- Oct 04, 2017 03:03 PM IST
Mitessh Thakkar of miteshthacker.com suggests buying IPCA Laboratories and PC Jeweller.
- Sep 22, 2017 02:20 PM IST
Pharma stocks have been on an upward trend. In an interview to CNBC-TV18, Deepak Malik, Pharma Analyst of Edelweiss Securities discussed what is happening in the sector.
- Aug 11, 2017 05:15 PM IST
Net total income of the company also declined to Rs 719.14 crore for the quarter under consideration as against Rs 859.54 crore for the same period a year ago.
- Aug 07, 2017 02:47 PM IST
Ipca is one of the worst affected companies by the US regulator's action.
- Jun 20, 2017 12:03 PM IST
Drug maker Ipca Laboratories on Tuesday said that US FDA hasn't carried out any new inspections at three of its manufacturing units under scanner.
- Jun 17, 2017 09:19 AM IST
Axis Mutual Fund A/C Axis Long Term Equity Fund sold 11,08,795 shares of Ipca Laboratories.
- Jun 16, 2017 09:20 AM IST
The ban of all drugs will continue until the company can demonstrate that the drugs manufactured sites and intended for the US market are in compliance with Current Good Manufacturing Practice (cGMP).
- Jun 01, 2017 04:37 PM IST
ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 525 in its research report dated May 31, 2017.
- Apr 12, 2017 03:28 PM IST
Given high price erosion in hydroxychloroquine, UBS believes US revenue could continue to be under pressure
- Mar 30, 2017 07:53 AM IST
Ashish Kyal of Waves Strategy Advisors advises selling Engineers India with a target of Rs 139.
- Mar 27, 2017 08:00 AM IST
Ashish Kyal of Waves Strategy Advisors advises buying Century Textiles with a target of Rs 1040.
- Mar 06, 2017 05:02 PM IST
Warning letters resolutions are taking more time than ever before. Only 9 out of 108 warning letters have been sorted taking an average of 500 days. Data for India and China is even bleaker with just one resolution out of the 64 WLs issued in past 52 months, according to Edelweiss report.
- Feb 21, 2017 03:11 PM IST
Axis Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 580 in its research report dated February 16, 2017.
- Feb 16, 2017 03:23 PM IST
ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 560 in its research report dated February 13, 2017.
- Jan 14, 2017 02:46 PM IST
The brokerage firm says that even on assuming only 12 percent Nifty earnings growth in FY18 due to spillâ€over of demonetisation, valuations are factoring much damage at price to earnings (PE) of 17 times.
- Jan 11, 2017 01:43 PM IST
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- IndusInd Bank, Shiva Cement, Suzlon Energy and Ipca Laboratories.
- Jan 11, 2017 01:33 PM IST
â€œThe third party consultants are regularly visiting our manufacturing units which are under USFDA import alert/warning letter and are assisting us in implementing robust remediation measures in a proper and timely manner,â€ Ipca said in a clarification to stock exchanges.
- Dec 13, 2016 04:15 PM IST
Rajesh Kothari, Managing Director at AlfAccurate Advisors has a bullish stance on Ipca Laboratories and feels that earnings growth can be very strong over the next 2-3 years.
- Nov 17, 2016 08:47 AM IST
Nomura maintains buy call with target unchanged at Rs 900 per share as volumes could improve further and margin may improve in second half.